Antiestrogen potentiation of antiproliferative effects of vitamin D3 analogues in breast cancer cells

Cancer Research

Volumn 56, Issue 12, 1996, Pages 2789-2794

  Love Schimenti, Cheryl D ^a   Gibson, David F C ^a   Ratnam, Anita V ^a   Bikle, Daniel D ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

16 ENE 1,25 DIHYDROXYVITAMIN D3; 16 ENE,23 YNE 1,25 DIHYDROXYVITAMIN D3; 22 OXACALCITRIOL; CALCITRIOL RECEPTOR; COLECALCIFEROL DERIVATIVE; ESTRADIOL RECEPTOR; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE; SEOCALCITOL; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER INHIBITION; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENTIATION; DRUG RECEPTOR BINDING; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR AFFINITY;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CALCITRIOL; CELL DIVISION; DRUG SCREENING ASSAYS, ANTITUMOR; DRUG THERAPY, COMBINATION; ESTRADIOL; ESTROGEN ANTAGONISTS; FEMALE; HUMANS; NEOPLASM PROTEINS; POLYUNSATURATED ALKAMIDES; RECEPTORS, CALCITRIOL; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0029889360     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Early Breast Cancer Trialists' Collaborative Group. Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women. N. Engl. J. Med., 319: 1681-1692, 1988.
2. Bikle, D. D. Vitamin D: new actions, new analogs, new therapeutic potential. Endocr. Rev., 13: 765-784, 1992
3. Walters, M R Newly identified actions of the vitamin D endocrine system. Endocr. Rev., 13 719-764, 1992.
4. Eisman, J. A., Martin, T. J., MacIntyre, I., and Moseley, J. M. 1,25-dihydroxyvitamin-D-receptor in breast cancer cells. Lancet, 2: 1335-1336, 1979.
5. 3 receptor in breast cancer. Cancer Res., 51, 239-244, 1987.
6. Colston, K. W., Berger, U., and Coombes, R. C. Possible role for vitamin D in controlling breast cancer cell proliferation. Lancet, 1: 188-191, 1989.
7. 3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia. Endocrinology, 129: 832-837, 1991.
8. 3. Cancer Res., 47: 21-25, 1987.
9. Abe-Hashimoto, J., Kikuchi, T., Matsumoto, T , Nishii, Y., Ogata, E., and Ikeda, K. Antitumor effect of 22-oxa-calcitriol, a noncalcemic analogue of calcitriol, in athymic mice implanted with human breast carcinoma and its synergism with tamoxifen Cancer Res , 53: 2534-2537, 1993
10. 3 analogues and tamoxifen. Cancer Res., 54: 5711-5717, 1994
11. James, S. Y., Mackay, A. G., Binderup, L., and Colston, K. W. Effects of a new synthetic vitamin D analogue, EB1089, on the oestrogen-responsive growth of human breast cancer cells. J. Endocrinol., 141: 555-563, 1994
12. 3 prolongs survival time of leukemic mice. Proc. Natl. Acad. Sci. USA. 87: 3929-3932, 1990.
13. LaBarca, C , and Paigen, K A simple, rapid, and sensitive DNA assay procedure Anal. Biochem., 102 344-352, 1980.
14. 3 during neonatal development in the rat J. Biol. Chem , 256: 7338-7342, 1981.
15. Scatchard, G The attractions of proteins for small molecules and ions. Ann. NY Acad Sci., 51, 660-672, 1949.
16. Itin, P. H , Pittelkow, M. R., and Kumar, R. Effects of vitamin D metabolites on proliferation and differentiation of cultured human epidermal keratinocytes grown in serum-free or defined culture medium. Endocrinology, 135: 1793-1798, 1994.
17. Bikle, D. D., Gee, E., and Pillai, S. Regulation of keratinocyte growth, differentiation, and vitamin D metabolism by analogs of 1,25-dihydroxyvitarmn D. J. Invest Dermatol, 101: 713-718, 1993.
18. Pillai, S , and Bikle, D. D. 1,25-dihydroxyvitamin D production and receptor binding in human keratinocytes varies with differentiation. J. Biol. Chem., 265: 5390-5395, 1988.
19. 3 are associated with enhanced activation of the vitamin D receptor. J. Biol. Chem., 270: 10551-10558, 1995.
20. Bikle, D. D., Abe-Hashimoto, A, Su, M-J.., Felt, S., Gibson, D F C., and Pillai, S. 22-oxa calcitriol is a less potent regulator of keratinocyte proliferation and differentiation due to decreased cellular uptake and enhanced catabolism. J. Invest. Dermatol., 105: 693-698, 1995
21. Wakeling, A. E , and Bowler, J. Steroidal pure antiestrogens. J Endocrinol., 112: R7-R10, 1987.
22. Ignar-Trowbridge, D. M., Teng, C. T , Ross, K. A., Parker, M. G , Korach, K. S., and McLachlan, J. A. Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element. Mol. Endocrinol., 7: 992-998, 1993.
23. Philips, A., Chalbos, D , and Rochefort, H. Estradiol increases and anti-estrogens antagonize the growth factor-induced activator protein-1 activity in MCF7 breast cancer cells without affecting c-fos and c-jun synthesis. J. Biol. Chem., 268: 14103-14108, 1993.
24. Newton, C J., Buric, R., Trapp, T., Brockmeier. S , Pagotto, U., and Stalla, G. K. The unliganded estrogen receptor (ER) transduces growth factor signals. J Steroid Biochem. Mol. Biol., 48: 481-486, 1994.